Login

Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Global Geological Cooperation: BGR's Technical Projects and International Partnerships
00:10:00
Opportunities Abound in the Startup Ecosystem|Leshika Samarasinghe,Founder and General Partner,Twine Ventures
00:10:00
Mark Little on Lazard Asset Management's International Equity Strategy | Mark Little - Managing Director and Portfolio Manager/Analyst at Lazard Asset Management
00:10:00
Europe’s Independent Hedge Fund Powerhouse with a Disciplined Edge and Global Reach|Dr Werner Goricki ,CIO,Prime Capital
00:10:00
Hans Wallenstam Reflects on Wallenstam's Strong Growth and Strategic Future | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
Summer 2023 Market Update: Key Trends and Outlook
00:00:00
William Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D. Neurologist, Mayo Clinic
00:10:00
Mike Gruss, Editor of C4ISRNET, engages with AeroVironment’s VP of Product Line Management - UAS, Gorik Hossepian, exploring the hurdles and prospects for the DoD in broadening the U.S. drone industrial base.
00:10:00
Entrevista com Rogério Jorge, CEO da AES Brasil, com foco na geração de energia no Brasil.
00:10:00
Philippe Brassac on Crédit Agricole's Strategic Response and Universality in Challenging Times | Philippe Brassac , CEO ,  Crédit Agricole SA .
00:10:00
Self-Storage Secrets to Financial Freedom: Insights from Caley Acevez - Caley Acevez | VP of Marketing | Cedar Creek Capital
00:10:00
Atlas Salt Announces "The Great Atlantic Build Team"

© 2017 - Neuhu+